SUPERNUS PHARMACEUTICALS INC (SUPN)

US8684591089 - Common Stock

35.43  -0.34 (-0.95%)

After market: 35.43 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
579.8M
11.41%
667.2M
15.07%
607.521M
-8.94%
655M
7.82%
633.26M
-3.32%
689.46M
8.87%
780.1M
13.15%
859.27M
10.15%
872.1M
1.49%
846.6M
-2.92%
867M
2.41%
EBITDA
YoY % growth
140.9M
-29.62%
131.6M
-6.60%
99.779M
-24.18%
123.41M
23.68%
168.76M
36.75%
152.22M
-9.80%
177.68M
16.73%
225.87M
27.12%
319.67M
41.53%
284.17M
-11.11%
246.02M
-13.43%
EBIT
YoY % growth
108.3M
-40.53%
46.1M
-57.43%
14.92M
-67.64%
173.71M
1,064.28%
114.2M
-34.26%
152.56M
33.59%
217.35M
42.47%
272.16M
25.22%
360.16M
32.33%
347.41M
-3.54%
374.75M
7.87%
Operating Margin
18.68%6.91%2.46%26.52%18.03%22.13%27.86%31.67%41.30%41.04%43.22%
EPS
YoY % growth
0.98
-58.47%
1.03
5.10%
1.40
35.92%
2.91
108.13%
1.93
-33.72%
2.38
23.24%
3.27
37.36%
4.13
26.37%
5.10
23.46%
4.95
-3.00%
5.30
7.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.51
-42.70%
0.40
54.31%
0.45
23.72%
0.52
-24.61%
0.56
10.00%
Revenue
Q2Q % growth
156.69M
-4.64%
143.31M
-0.23%
153.92M
-8.56%
163.27M
-7.07%
169.86M
8.41%
EBITDA
Q2Q % growth
34.384M
-66.95%
44.37M
152.16%
44.574M
-30.39%
49.572M
-51.60%
47.022M
36.76%
EBIT
Q2Q % growth
30.503M
58.93%
23.494M
845.13%
29.036M
28.65%
34.17M
-16.34%
39.372M
29.08%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.69
187.50%
0.450.2452.59%
Q2 2024
Q2Q % growth
0.36
1,900.00%
0.40-0.04-9.50%
Q1 2024
Q2Q % growth
0.26
-10.34%
0.38-0.12-32.33%
Q4 2023
Q2Q % growth
0.89
106.98%
0.560.3357.69%
Q3 2023
Q2Q % growth
0.24
700.00%
0.080.16194.12%
Q2 2023
Q2Q % growth
-0.02
-114.29%
0.07-0.09-130.17%
Q1 2023
Q2Q % growth
0.29
-32.56%
0.170.1267.24%
Q4 2022
Q2Q % growth
0.43
975.00%
0.69-0.26-38.00%
Q3 2022
Q2Q % growth
0.03
-92.50%
0.36-0.33-91.75%
Q2 2022
Q2Q % growth
0.14
-67.44%
0.30-0.16-52.67%
Q1 2022
Q2Q % growth
0.43
290.91%
0.240.1975.65%
Q4 2021
Q2Q % growth
0.04
-92.98%
0.24-0.20-83.43%
Q3 2021
Q2Q % growth
0.40
-45.95%
0.240.1668.67%
Q2 2021
Q2Q % growth
0.43
-33.85%
0.200.23113.45%
Q1 2021
Q2Q % growth
0.11
-72.50%
0.25-0.14-55.53%
Q4 2020
Q2Q % growth
0.57
-8.06%
0.530.047.99%
Q3 2020
Q2Q % growth
0.74
37.04%
0.300.44143.86%
Q2 2020
Q2Q % growth
0.65
6.56%
0.430.2251.73%
Q1 2020
Q2Q % growth
0.40
17.65%
0.290.1139.06%
Q4 2019
Q2Q % growth
0.62
29.17%
0.620.000.75%
Q3 2019
Q2Q % growth
0.54
3.85%
0.61-0.07-11.76%
Q2 2019
Q2Q % growth
0.61
7.02%
0.590.023.11%
Q1 2019
Q2Q % growth
0.34
-30.61%
0.48-0.14-29.45%
Q4 2018
Q2Q % growth
0.48 0.280.2072.17%
Q3 2018
Q2Q % growth
0.52 0.420.1024.95%
Q2 2018
Q2Q % growth
0.57 0.440.1329.96%
Q1 2018
Q2Q % growth
0.49 0.330.1647.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
175.689M
14.17%
160.44M15.249M9.50%
Q2 2024
Q2Q % growth
168.325M
24.17%
151.83M16.495M10.86%
Q1 2024
Q2Q % growth
143.644M
-6.58%
148.75M-5.106M-3.43%
Q4 2023
Q2Q % growth
164.314M
-1.78%
158.13M6.184M3.91%
Q3 2023
Q2Q % growth
153.88M
-13.26%
146.25M7.63M5.22%
Q2 2023
Q2Q % growth
135.563M
-20.30%
146.53M-10.967M-7.48%
Q1 2023
Q2Q % growth
153.764M
0.83%
141.8M11.964M8.44%
Q4 2022
Q2Q % growth
167.3M
5.15%
183.98M-16.68M-9.07%
Q3 2022
Q2Q % growth
177.4M
19.46%
175.93M1.47M0.84%
Q2 2022
Q2Q % growth
170.1M
20.38%
167.51M2.59M1.55%
Q1 2022
Q2Q % growth
152.5M
16.50%
153.48M-980K-0.64%
Q4 2021
Q2Q % growth
159.1M
10.79%
155.77M3.33M2.14%
Q3 2021
Q2Q % growth
148.5M
-4.26%
144.96M3.54M2.44%
Q2 2021
Q2Q % growth
141.3M
11.52%
137.57M3.73M2.71%
Q1 2021
Q2Q % growth
130.9M
37.79%
131.78M-880K-0.67%
Q4 2020
Q2Q % growth
143.6M
43.03%
149.11M-5.51M-3.70%
Q3 2020
Q2Q % growth
155.1M
51.91%
133.27M21.83M16.38%
Q2 2020
Q2Q % growth
126.7M
21.01%
100.06M26.64M26.62%
Q1 2020
Q2Q % growth
95M
11.11%
85.151M9.849M11.57%
Q4 2019
Q2Q % growth
100.4M
-13.37%
113.76M-13.36M-11.74%
Q3 2019
Q2Q % growth
102.1M
-0.87%
112.03M-9.93M-8.86%
Q2 2019
Q2Q % growth
104.7M
5.23%
111.89M-7.19M-6.43%
Q1 2019
Q2Q % growth
85.5M
-5.42%
105.65M-20.15M-19.07%
Q4 2018
Q2Q % growth
115.9M 107.57M8.33M7.74%
Q3 2018
Q2Q % growth
103M 102.62M380K0.37%
Q2 2018
Q2Q % growth
99.5M 101.4M-1.9M-1.87%
Q1 2018
Q2Q % growth
90.4M 86.72M3.68M4.24%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 7.91% 9.45% 41.42%
Revenue0% -0.42% 0% 3.29%